Cargando…
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321614/ https://www.ncbi.nlm.nih.gov/pubmed/22547909 http://dx.doi.org/10.1155/2012/858692 |
_version_ | 1782228965505630208 |
---|---|
author | Vasic, Dusica Walcher, Daniel |
author_facet | Vasic, Dusica Walcher, Daniel |
author_sort | Vasic, Dusica |
collection | PubMed |
description | Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients. |
format | Online Article Text |
id | pubmed-3321614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33216142012-04-30 C-Peptide: A New Mediator of Atherosclerosis in Diabetes Vasic, Dusica Walcher, Daniel Mediators Inflamm Review Article Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients. Hindawi Publishing Corporation 2012 2012-03-22 /pmc/articles/PMC3321614/ /pubmed/22547909 http://dx.doi.org/10.1155/2012/858692 Text en Copyright © 2012 D. Vasic and D. Walcher. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Vasic, Dusica Walcher, Daniel C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title_full | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title_fullStr | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title_full_unstemmed | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title_short | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
title_sort | c-peptide: a new mediator of atherosclerosis in diabetes |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321614/ https://www.ncbi.nlm.nih.gov/pubmed/22547909 http://dx.doi.org/10.1155/2012/858692 |
work_keys_str_mv | AT vasicdusica cpeptideanewmediatorofatherosclerosisindiabetes AT walcherdaniel cpeptideanewmediatorofatherosclerosisindiabetes |